# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 14P


The holder of the authorisation shall conduct regular reviews of the arrangements for supervision and control of the manufacture or assembly operations at each POC (IMP) site and ensure that, where appropriate, remedial action is taken as soon as reasonably practicable.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/7/paragraph/14P (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-7/paragraph-14P
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.